Neurology

Contineum Therapeutics

Clinical-stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for neuroscience, inflammation and immunology (NI&I) indications with high unmet need

 

Red Tree Participation
Co-investor in Series C
Total Addressable Market

$20 billion+

Red Tree Board Member(s)
Red Tree Participation
Co-investor in Series C

Contineum Therapeutics

Neurology
Total Addressable Market

$20 billion+

Red Tree Board Member(s)
Red Tree Participation
Co-investor in Series C